Fluge & Mella's pre-trial study highlights life-changing potential of rituximab
Sasha gives the background and Simon gives the interpretation of the latest study from Haukeland, published today...
Discuss the article on the Forums.

Gilenya approved for MS

Discussion in 'General Treatment' started by zoe.a.m., Sep 23, 2010.

  1. zoe.a.m.

    zoe.a.m. Senior Member

    Olympic Peninsula, Washington
    I just got news of this today and wonder if it might be helpful knowledge for someone! It appears to keep lymphocytes in the lymph nodes and keeps them from attacking the CNS. Sounds like a rough trade off in many ways and probably not a good choice for ME/CFS, but good to see a European drug company taking a stab at new treatments for chronic illnesses.


See more popular forum discussions.

Share This Page